Medical treatment of uterocutaneous fistula with gonadotropin-releasing hormone agonist administration.

Seyhan, Ayse; Ata, Baris; Sidal, Bilhan; Urman, Bulent · Obstet Gynecol · 2008

case_report · Level V

Where this comes from

Abstract

Uterocutaneous fistula is a rare complication of uterine surgery. All published cases have been surgically treated with hysterectomy and excision of the fistulous tract. We report a case of uterocutaneous fistula that was successfully treated with gonadotropin-releasing hormone agonist administration. A 25-year-old woman reported bloody discharge during her periods from a previous Pfannenstiel incision. A fistulous tract leading from the incision scar to the uterus was diagnosed. Leuprolide acetate depot was administered twice subcutaneously at a dose of 11.25 mg. The fistulous tract closed spontaneously, and the patient was symptom free thereafter. Medical treatment with gonadotropin-releasing hormone agonists should be considered before resorting to surgery for treatment of uterocutaneous fistulae.

Medical subject headings